Award
Vanderbilt University 5R50CA211206-10
Cancer Pharmacologist and HTS Scientist
Recipient
Vanderbilt University
Award Amount
$218,965.00
Ceiling
$218,965.00
Awarded
August 15, 2025
Identifier
5R50CA211206-10
Award for a Cancer Pharmacologist and HTS Scientist at Vanderbilt University to conduct cancer-related research involving high-throughput screening and drug discovery, funded by the National Cancer Institute for fiscal year 2025.
Description
The project involves high-throughput screening (HTS) and drug discovery to identify novel drug targets and understand mechanisms of cancer cell response to therapeutics. The award is funded by the National Cancer Institute (NCI) for the fiscal year 2025, with a project duration from September 1, 2025, to August 31, 2026. The principal investigator is Joshua A. Bauer, a Research Assistant Professor at Vanderbilt University.